Skip to main content
Top
Published in: Clinical and Translational Oncology 5/2024

05-09-2023 | Hysteroscopy | RESEARCH ARTICLE

Endometrial cancer: predictors and oncological safety of tumor tissue manipulation

Authors: Raquel Quintana-Bertó, Pablo Padilla-Iserte, Víctor Lago, Carmen Tauste, Berta Díaz-Feijoo, Silvia Cabrera, Reyes Oliver-Pérez, Pluvio J. Coronado, María Belén Martín-Salamanca, Manuel Pantoja-Garrido, Josefa Marcos-Sanmartin, Eduardo Cazorla, Cristina Lorenzo, José Ramón Rodríguez-Hernández, Fernando Roldán-Rivas, Juan Gilabert-Estellés, Juan Carlos Muruzábal, Antonio Cañada, Santiago Domingo, SEGO Spain-GOG Group

Published in: Clinical and Translational Oncology | Issue 5/2024

Login to get access

Abstract

Purpose

The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results.

Methods

We performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for apparently early-stage endometrial cancer. A multivariate statistical analysis model was designed to assess the impact that tumor manipulation (with the use of uterine manipulator or preoperative hysteroscopy) has on lympho-vascular development (LVSI) in the final surgical specimen.

Results

A total of 2852 women from 15 centers were included and divided into two groups based on the lympho-vascular status in the final surgical specimen: 2265 (79.4%) had no LVSI and 587 (20.6%) presented LVSI. The use of uterine manipulator was associated with higher chances of lympho-vascular involvement regardless of the type used: Balloon manipulator (HR: 95% CI 4.64 (2.99–7.33); p < 0.001) and No-Balloon manipulator ([HR]: 95% CI 2.54 (1.66–3.96); p < 0.001). There is no evidence of an association between the use of preoperative hysteroscopy and higher chances of lympho-vascular involvement (HR: 95% CI 0.90 (0.68–1.19); p = 0.479).

Conclusion

Whilst performing common gynecological procedures, iatrogenic distention and manipulation of the uterine cavity are produced. Our study suggests that the use of uterine manipulator increases the rate of LVSI and, therefore, leads to poorer oncological results. Conversely, preoperative hysteroscopy does not show higher rates of LVSI involvement in the final surgical specimen and can be safely used.
Literature
1.
go back to reference Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.CrossRefPubMed Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.CrossRefPubMed
2.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed
3.
go back to reference Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.CrossRefPubMed Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.CrossRefPubMed
4.
go back to reference Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12–39.CrossRefPubMed Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12–39.CrossRefPubMed
5.
go back to reference Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, et al. International society of gynecological pathologists (ISGyP) endometrial cancer project: guidelines from the special techniques and ancillary studies group. Int J Gynecol Pathol. 2019;38:S114–22.CrossRefPubMed Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, et al. International society of gynecological pathologists (ISGyP) endometrial cancer project: guidelines from the special techniques and ancillary studies group. Int J Gynecol Pathol. 2019;38:S114–22.CrossRefPubMed
6.
go back to reference Jorge S, Hou JY, Tergas AI, Burke WM, Huang Y, Hu JC, et al. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer. Gynecol Oncol. 2016;140(3):387–93.CrossRefPubMedPubMedCentral Jorge S, Hou JY, Tergas AI, Burke WM, Huang Y, Hu JC, et al. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer. Gynecol Oncol. 2016;140(3):387–93.CrossRefPubMedPubMedCentral
7.
go back to reference Hahn HS, Lee IH, Kim TJ, Lee KH, Shim JU, Kim JW, et al. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Aust N Z J Obstet Gynaecol. 2013;53(3):293–7.CrossRefPubMed Hahn HS, Lee IH, Kim TJ, Lee KH, Shim JU, Kim JW, et al. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Aust N Z J Obstet Gynaecol. 2013;53(3):293–7.CrossRefPubMed
8.
go back to reference Bosse T, Peters EEM, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Mens JWM, et al. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer—a pooled analysis of PORTEC 1 and 2 trials. Eur J Cancer. 2015;51(13):1742–50.CrossRefPubMed Bosse T, Peters EEM, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Mens JWM, et al. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer—a pooled analysis of PORTEC 1 and 2 trials. Eur J Cancer. 2015;51(13):1742–50.CrossRefPubMed
9.
go back to reference Padilla-Iserte P, Lago V, Tauste C, Díaz-Feijoo B, Gil-Moreno A, Oliver R, et al. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery. Am J Obstet Gynecol. 2021;224(1):65.e1-65.e11.CrossRefPubMed Padilla-Iserte P, Lago V, Tauste C, Díaz-Feijoo B, Gil-Moreno A, Oliver R, et al. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery. Am J Obstet Gynecol. 2021;224(1):65.e1-65.e11.CrossRefPubMed
10.
go back to reference Logani S, Herdman AV, Little JV, Moller KA. Vascular “pseudo invasion” in laparoscopic hysterectomy specimens: a diagnostic pitfall. Am J Surg Pathol. 2008;32(4):560–5.CrossRefPubMed Logani S, Herdman AV, Little JV, Moller KA. Vascular “pseudo invasion” in laparoscopic hysterectomy specimens: a diagnostic pitfall. Am J Surg Pathol. 2008;32(4):560–5.CrossRefPubMed
11.
go back to reference Takac I, Zegura B. Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer. Gynecol Oncol. 2007;107(1):94–8.CrossRefPubMed Takac I, Zegura B. Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer. Gynecol Oncol. 2007;107(1):94–8.CrossRefPubMed
12.
go back to reference Dewdney SB, Jiao Z, Roma AA, Gao F, Rimel BJ, Thaker PH, et al. The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancer. Eur J Gynaecol Oncol. 2014;35(1):7–10.PubMed Dewdney SB, Jiao Z, Roma AA, Gao F, Rimel BJ, Thaker PH, et al. The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancer. Eur J Gynaecol Oncol. 2014;35(1):7–10.PubMed
13.
go back to reference Radley-Gardner O, Beale H, Zimmermann R. Fundamental texts on European private law. Oxford: Hart Publishing; 2016.CrossRef Radley-Gardner O, Beale H, Zimmermann R. Fundamental texts on European private law. Oxford: Hart Publishing; 2016.CrossRef
14.
go back to reference Kim S, Park HK, Jung HY, Lee SY, Min KW, Kim WY, et al. ERG Immunohistochemistry as an endothelial marker for assessing lymphovascular invasion. Korean J Pathol. 2013;47(4):355–64.CrossRefPubMedPubMedCentral Kim S, Park HK, Jung HY, Lee SY, Min KW, Kim WY, et al. ERG Immunohistochemistry as an endothelial marker for assessing lymphovascular invasion. Korean J Pathol. 2013;47(4):355–64.CrossRefPubMedPubMedCentral
15.
go back to reference Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed
16.
18.
go back to reference Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for cox’s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1.CrossRefPubMedPubMedCentral Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for cox’s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1.CrossRefPubMedPubMedCentral
19.
go back to reference Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York Berlin Heidelberg: Springer; 2000. p. 350.CrossRef Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York Berlin Heidelberg: Springer; 2000. p. 350.CrossRef
20.
go back to reference Gorostidi Pulgar M, Diaz de la Noval B, Gil-Ibañez B, Lago Leal V, Jaunarena Marin I, Padilla IP. Lymphovascular space invasion for endometrial cancer: undertreatment and overtreatment risks. Int J Gynecol Cancer. 2017;27(6):1191–9.CrossRefPubMed Gorostidi Pulgar M, Diaz de la Noval B, Gil-Ibañez B, Lago Leal V, Jaunarena Marin I, Padilla IP. Lymphovascular space invasion for endometrial cancer: undertreatment and overtreatment risks. Int J Gynecol Cancer. 2017;27(6):1191–9.CrossRefPubMed
21.
go back to reference Capozzi VA, Rosati A, Uccella S, Riemma G, Tarascio M, Torella M, et al. Role of uterine manipulator during laparoscopic endometrial cancer treatment. Transl Cancer Res. 2020;9(12):7759–66.CrossRefPubMedPubMedCentral Capozzi VA, Rosati A, Uccella S, Riemma G, Tarascio M, Torella M, et al. Role of uterine manipulator during laparoscopic endometrial cancer treatment. Transl Cancer Res. 2020;9(12):7759–66.CrossRefPubMedPubMedCentral
22.
go back to reference Gueli Alletti S, Perrone E, Cretì A, Cianci S, Uccella S, Fedele C, et al. Feasibility and perioperative outcomes of percutaneous-assisted laparoscopic hysterectomy: a multicentric Italian experience. Eur J Obstet Gynecol Reprod Biol. 2020;245:181–5.CrossRefPubMed Gueli Alletti S, Perrone E, Cretì A, Cianci S, Uccella S, Fedele C, et al. Feasibility and perioperative outcomes of percutaneous-assisted laparoscopic hysterectomy: a multicentric Italian experience. Eur J Obstet Gynecol Reprod Biol. 2020;245:181–5.CrossRefPubMed
23.
go back to reference van den Haak L, Alleblas C, Nieboer TE, Rhemrev JP, Jansen FW. Efficacy and safety of uterine manipulators in laparoscopic surgery: a review. Arch Gynecol Obstet. 2015;292(5):1003–11.CrossRefPubMed van den Haak L, Alleblas C, Nieboer TE, Rhemrev JP, Jansen FW. Efficacy and safety of uterine manipulators in laparoscopic surgery: a review. Arch Gynecol Obstet. 2015;292(5):1003–11.CrossRefPubMed
24.
go back to reference Abdel Khalek Y, Bitar R, Christoforou C, Garzon S, Tropea A, Biondi A, et al. Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness. Updat Surg. 2020;72(4):1247–54.CrossRef Abdel Khalek Y, Bitar R, Christoforou C, Garzon S, Tropea A, Biondi A, et al. Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness. Updat Surg. 2020;72(4):1247–54.CrossRef
25.
go back to reference Krizova A, Clarke BA, Bernardini MQ, James S, Kalloger SE, Boerner SL, et al. Histologic artifacts in abdominal, vaginal, laparoscopic, and robotic hysterectomy specimens: a blinded retrospective review. Am J Surg Pathol. 2011;35(1):115–26.CrossRefPubMed Krizova A, Clarke BA, Bernardini MQ, James S, Kalloger SE, Boerner SL, et al. Histologic artifacts in abdominal, vaginal, laparoscopic, and robotic hysterectomy specimens: a blinded retrospective review. Am J Surg Pathol. 2011;35(1):115–26.CrossRefPubMed
26.
go back to reference Kitahara S, Walsh C, Frumovitz M, Malpica A, Silva EG. Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact? Am J Surg Pathol. 2009;33(2):298–303.CrossRefPubMed Kitahara S, Walsh C, Frumovitz M, Malpica A, Silva EG. Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact? Am J Surg Pathol. 2009;33(2):298–303.CrossRefPubMed
27.
go back to reference Machida H, Hom MS, Adams CL, Eckhardt SE, Garcia-Sayre J, Mikami M, et al. Intrauterine manipulator use during minimally invasive hysterectomy and risk of lymphovascular space invasion in endometrial cancer. Int J Gynecol Cancer. 2018;28(2):208–19.CrossRefPubMedPubMedCentral Machida H, Hom MS, Adams CL, Eckhardt SE, Garcia-Sayre J, Mikami M, et al. Intrauterine manipulator use during minimally invasive hysterectomy and risk of lymphovascular space invasion in endometrial cancer. Int J Gynecol Cancer. 2018;28(2):208–19.CrossRefPubMedPubMedCentral
28.
go back to reference Seifi F, Parkash V, Clark M, Menderes G, Tierney C, Silasi DA, et al. Pseudovascular invasion: minimally invasive surgery for endometrial cancer. JSLS. 2019;23(2):e2019.00021.CrossRefPubMedPubMedCentral Seifi F, Parkash V, Clark M, Menderes G, Tierney C, Silasi DA, et al. Pseudovascular invasion: minimally invasive surgery for endometrial cancer. JSLS. 2019;23(2):e2019.00021.CrossRefPubMedPubMedCentral
29.
go back to reference Mariani A, Dowdy SC, Podratz KC. New surgical staging of endometrial cancer: 20 years later. Int J Gynecol Obstet. 2009;105(2):110–1.CrossRef Mariani A, Dowdy SC, Podratz KC. New surgical staging of endometrial cancer: 20 years later. Int J Gynecol Obstet. 2009;105(2):110–1.CrossRef
30.
go back to reference Sáinz de la Cuesta R, Espinosa JA, Crespo E, Granizo JJ, Rivas F. Does fluid hysteroscopy increase the stage or worsen the prognosis in patients with endometrial cancer? A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2004;115(2):211–5.CrossRefPubMed Sáinz de la Cuesta R, Espinosa JA, Crespo E, Granizo JJ, Rivas F. Does fluid hysteroscopy increase the stage or worsen the prognosis in patients with endometrial cancer? A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2004;115(2):211–5.CrossRefPubMed
32.
go back to reference Cicinelli E, Tinelli R, Colafiglio G, Fortunato F, Fusco A, Mastrolia S, et al. Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study. Menopause N Y N. 2010;17(3):511–5.CrossRef Cicinelli E, Tinelli R, Colafiglio G, Fortunato F, Fusco A, Mastrolia S, et al. Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study. Menopause N Y N. 2010;17(3):511–5.CrossRef
33.
go back to reference Namazov A, Gemer O, Helpman L, Hag-Yahia N, Eitan R, Raban O, et al. The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: an Israel gynecologic oncology group study. Eur J Obstet Gynecol Reprod Biol. 2019;243:120–4.CrossRefPubMed Namazov A, Gemer O, Helpman L, Hag-Yahia N, Eitan R, Raban O, et al. The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: an Israel gynecologic oncology group study. Eur J Obstet Gynecol Reprod Biol. 2019;243:120–4.CrossRefPubMed
34.
go back to reference Chang YN, Zhang Y, Wang YJ, Wang LP, Duan H. Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis. Fertil Steril. 2011;96(4):957-961.e2.CrossRefPubMed Chang YN, Zhang Y, Wang YJ, Wang LP, Duan H. Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis. Fertil Steril. 2011;96(4):957-961.e2.CrossRefPubMed
Metadata
Title
Endometrial cancer: predictors and oncological safety of tumor tissue manipulation
Authors
Raquel Quintana-Bertó
Pablo Padilla-Iserte
Víctor Lago
Carmen Tauste
Berta Díaz-Feijoo
Silvia Cabrera
Reyes Oliver-Pérez
Pluvio J. Coronado
María Belén Martín-Salamanca
Manuel Pantoja-Garrido
Josefa Marcos-Sanmartin
Eduardo Cazorla
Cristina Lorenzo
José Ramón Rodríguez-Hernández
Fernando Roldán-Rivas
Juan Gilabert-Estellés
Juan Carlos Muruzábal
Antonio Cañada
Santiago Domingo
SEGO Spain-GOG Group
Publication date
05-09-2023
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 5/2024
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-023-03310-6

Other articles of this Issue 5/2024

Clinical and Translational Oncology 5/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine